INTRODUCTION
Herpes simplex virus (HSV), after primary infection in peripheral mucocutaneous tissue, can penetrate nerve cells and establish latent infection in neuronal ganglia (Challberg and Kelly, 1989; Roizman and Sears, 1990) . Re-infection with the same virus type has been described in humans, but it is extremely rare; most recurrent infections represent re-activation of the same virus type from latency. Although the molecular mechanism leading to viral re-activation is still unclear, it is known that re-activation is the viral answer to environmental injury to the host cell. For example, ultraviolet light, trauma to neuronal ganglia, immunosuppression or general stress situations could damage the host cell and seriously compromise virus survival (Roizman and Sears, 1990) . Starting in the lytic cycle, HSV suppresses host DNA and protein synthesis (Roizman and Sears, 1990) and induces its enzymic machinery controlling the efficient biosynthesis of DNA precursors, the replication of its genome, and the maturation of the virus particle.
Among the variety of enzymes induced by HSV during the reactivation event, some replace the suppressed host counterparts, for instance dUTPase (Caradonna and Cheng, 1981) , and others supply cellular enzymes that are lacking. The enzymes of this second class are either those catalysing specific viral reactions, such as virus assembly, or those whose cellular counterparts are developmentally absent, such as DNA polymerases and thymidine kinase (TK) .
Our laboratory has demonstrated that adult neurons lack not only TK, but also replicative DNA polymerases a (Hiibscher et al., 1977 (Hiibscher et al., , 1978 and d/e , and uracil-DNA n-butyl < p-n-pentyl = p-n-hexyl < p-n-heptyl < p-n-octyl. The most potent HSV1 enzyme inhibitor, 6-(p-n-octylanilino)uracil (OctAU), with an IC50 of 8 ,uM, was highly selective for the viral enzyme. thymidine incorporation into the DNA of HeLa cells in culture was partially inhibited by OctAU, whereas it was unchanged when 6-(p-n-hexylanilino)uracil was present at concentrations that completely inhibited HSV1 uracil-DNA glycosylase activity. These compounds represent the first class of inhibitors that inhibit HSV1 uracil-DNA glycosylase at concentrations in the micromolar range. The results suggest their possible use to evaluate the functional role of HSV1 uracil-DNA glycosylase in viral infections and re-activation in nerve cells.
glycosylase . In neurons, the activity of these enzymes decreases during fetal development and disappears at birth, in synchrony with the pattern of neural division (Hiibscher et al., 1977 (Hiibscher et al., , 1978 Spadari et al., 1988; Focher et al., 1990) . This means that in neurons, where viral re-activation takes place, HSV replication strictly depends on its own enzymes. This is supported by the observation that TK-HSV can sustain lytic infections in mucosal and skin surfaces (TK+ cells), but fails to re-activate from adult explanted ganglia (TK-cells).
The pivotal role of HSV TK in re-activation was clearly demonstrated by the use of non-substrate inhibitors of viral TK synthesized and characterized in our laboratories Spadari and Wright, 1989) . Used in a murine model, these compounds significantly reduced the number of latently infected trigeminal ganglia that yielded virus upon explant culture (Leib et al., 1990) .
Induction of HSV uracil-DNA glycosylase activity was observed during viral infection (Caradonna and Cheng, 1981) , and the coding sequence of the viral enzyme has been identified (Caradonna et al., 1987; Mullaney et al., 1989; Worrad and Caradonna, 1988) . Uracil-DNA glycosylase belongs to the class of enzymes involved in post-replicative DNA repair processes. Its function consists of the specific removal of uracil residues from DNA, deriving either from cytosine deamination or dUTP incorporation, by cleavage of the N-glycosidic bond linking the base to the deoxyribose phosphate backbone.
In this work, we present details of the isolation and characterization of the enzyme from HSVl-infected cells, and report the first specific inhibitors of HSV1 uracil-DNA glycosylase acting in the micromolar range. These compounds Abbreviations used: HSV1, Herpes simplex virus type 1; TK, thymidine kinase; PMSF, phenylmethanesulphonyl fluoride; DTT, dithiothreitol; NP-40, Nonidet P-40; DMEM, Dulbecco's modified Eagle's medium; BuAU, 6-(p-n-butylanilino)uracil; OctAU, 6-(p-n-octylanilino)uracil; HexAU, 6-(p-nhexylanilino)uracil.
1 1 To whom correspondence should be addressed. § To whom reprint requests should be addressed. (Ejercito et al., 1968) at a multiplicity of infection of 5 plaque-forming units/cell. After a 1 h adsorption period, the monolayers were rinsed twice with phosphate-buffered saline, overlaid with Dulbecco's modified Eagle's medium (DMEM) containing 10 % fetal calf serum, and incubated for 8 h. The cells were then detached with a rubber policeman, the suspension was divided into portions in plastic tubes, and cells were kept frozen at -70°C until use.
Uracil-DNA glycosylase assay Assays in a final volume of 25,1 each contained 100 mM Tris/HCl (pH 8.0), 5 mM DTT, 10 mM EDTA, 500 ng of [3H]dUMP-labelled DNA (40 c.p.m./ng; 220 c.p.m./pmol of uracil; 3.6 1sM uracil) prepared as described , 4 ,ug of unlabelled activated DNA and the enzyme (0.3 unit) to be tested (when HSV1 enzyme was used, BSA was added in the test tube in order to obtain a protein concentration comparable with that for the human enzyme). After incubation at 37°C for 30 min, 20 ,tl portions of the mixtures were spotted on to GF/C filters (Whatman). The filters were washed three times in 5 % (v/v) trichloroacetic acid for 5-10 min and twice in ethanol. The filters were dried and the acid-insoluble radioactivity was measured by scintillation counting in 1 ml of scintillation fluid. One unit of uracil-DNA glycosylase removes 1 umol of uracil from DNA in 1 h at 37 'C.
PurfflcatIon of HSV1 uracil-DNA glycosylase HeLa cells (5 x 108) were infected by HSV1 as described above and collected 8 h post-infection. The cells were resuspended in 6 vol. of ice-cold buffer A (1O mM NaCl, 1 mM potassium phosphate, pH 6.8, 1 mM DTT and 1 % dimethyl sulphoxide, containing 0.2 mM PMSF, 4 mM sodium metabisulphite and 1 ,uM pepstatin). After 5 min on ice the cells were homogenized in a Dounce homogenizer. The homogenate was centrifuged at 1400 g for 15 min in order to precipitate the nuclei. The nuclei were suspended in 5 vol. ofbuffer B (1 mM potassium phosphate, pH 7.0, 0.32 M sucrose, 1 mM MgCl2, 0.3 % NP-40 detergent and 1 mM DTT, containing 0.2 mM PMSF, 4 mM sodium metabisulphite and 1 ,uM pepstatin). In this buffer the nuclei were homogenized and centrifuged at 1400 g for 15 min. The nuclear pellet was resuspended in 5 vol. of buffer C (400 mM potassium phosphate, pH 7.0, 1 mM DTT, 0.1 % NP-40 and 1 % dimethyl sulphoxide, containing 1 mM PMSF, 4 mM sodium metabisulphite and 1 ,uM pepstatin). After 5 min on ice the nuclei were disrupted in a Dounce homogenizer. The homogenate was centrifuged at 48000 g for 1 h. The supernatant was loaded on a DE-32 column (4 ml) previously equilibrated with 10 column volumes of buffer C (to remove nucleic acids). The flow-through and the first 20 ml of column wash with buffer C were collected and dialysed against three changes of buffer D (20 mM potassium phosphate, pH 7.5, 1 mM DTT and 0.1 % NP-40, containing 0.2 mM PMSF, 4 mM sodium metabisulphite and 1 ,cM pepstatin) in order to lower the ionic strength. The dialysed solution was loaded on to a DE-32 column (4 ml) previously equilibrated with buffer D. The flow-through and the first 16 ml of the column wash with buffer D containing the enzyme activity were loaded on to a phosphocellulose column (2 ml) equilibrated with buffer E (20 mM potassium phosphate, pH 7.5, 20 % glycerol, 1 mM DTT and 0.1 % NP-40, containing 0.2 mM PMSF, 4 mM sodium metabisulphite and 1 ,#M pepstatin). The phosphocellulose column was washed with 4 column volumes of buffer E, and the enzyme was eluted with 20 ml of a linear gradient from 20 to 400 mM potassium phosphate (pH 7.5) in buffer E. The pooled fractions, which eluted at approx. 200 mM potassium phosphate, were dialysed against buffer F (20 mM potassium phosphate, pH 7.0, 30 % glycerol, 1 mM DTT, 0.5 mM EDTA and 0.1 mM EGTA, containing 0.2 mM PMSF and 1 ,uM pepstatin), and then loaded on to a heparin-Sepharose column (1 ml) equilibrated with buffer F. The column was washed with 4 ml of buffer F, and the enzyme was eluted with 18 ml of a linear gradient from 0 to 600 mM KCI in buffer F; the enzyme eluted at 250 mM KCI. The pooled fractions were immediately frozen and stored in liquid nitrogen in small aliquots. The final preparation had a specific activity of 11080 units/mg and there was no contamination by nucleases. The sedimentation coefficient was 3.17. The purification procedure is summarized in Table 1 .
Purfficaton of human uracil-DNA glycosylase Human uracil-DNA glycosylase was purified from the cytoplasm of HeLa cells by a procedure partially derived from that of Krokan and Wittwer (1981) . HeLa-S3 cells (2 x 109) were resuspended in 28 ml of ice-cold buffer G (1O mM Tris/HCl, pH 7.5,3 mM MgCl2, 2 mM EGTA and 1 mM DTT, containing 0.2 mM PMSF, 4 mM sodium metabisulphite and 1 ,uM pepstatin). After 5 min on ice the cells were homogenized in a Dounce homogenizer, and then 14 ml of buffer H (340 mM Tris/HCl, pH 8.1, 3 mM MgCl2, 150 mM glucose, 2 mM EGTA, 0.15 % Triton X-100 and 1 mM DTT, containing 0.2 mM PMSF, 4 mM sodium metabisulphite and 1 #tM pepstatin) was added.
The resulting solution was centrifuged at 680 g for 5 min. The supernatant was saved, and the pellet containing the nuclei was washed in a Dounce homogenizer in 8 ml of buffer I (buffer G/buffer H, 2: 1, v/v) and then centrifuged at 680 g for 5 min. The supernatant was combined with the previous one and centrifuged at 100000 g for 1 h. The derived supernatant was dialysed for 8 h against 20 vol. of buffer J (20 mM Tris/HCl, pH 7.5, 20 % glycerol, 0.1 0% Triton X-100 and 1 mM DTT, containing 0.2 mM PMSF, 4 mM sodium metabisulphite and 1 ,uM pepstatin) and then loaded on to a DE-32 column (10 ml) equilibrated with buffer J. The flow-through and the column wash with buffer J containing the enzyme activity were loaded on to a phosphocellulose column (5 ml) equilibrated with buffer K (20 mM potassium phosphate, pH 7.5, 20 % glycerol, 0.1 % Triton X-100 and 1 mM DTT, containing 0.2 mM PMSF, 4 mM sodium metabisulphite and 1 ,uM pepstatin). The column was washed with 10 column volumes of buffer K, and the enzyme was eluted with a linear gradient (50 ml) of 20-300 mM potassium Table 2 Yields and properties of 6-(p-alkylanilino)uracils
Compounds were synthesized by reaction between 6-chlorouracil and the aniline in refluxing 2-methoxyethanol as described phosphate, pH 7.5, in buffer K. The pooled fractions (15 ml) were dialysed against 500 ml of buffer L (20 mM potassium phosphate, pH 7.0, 30% glycerol, 0.5 mM EDTA, 0.1 mM EGTA, 0.2 mM PMSF and 1 ,#M pepstatin) and then loaded on to a heparin-Sepharose column (1 ml) equilibrated with buffer L.
The column was washed with 20 ml of buffer L, and the enzyme was eluted with a linear gradient (10 ml) of 0-600 mM KCI in buffer L. The enzyme was further purified as follows: 100,l portions of the pooled fractions from the heparin-Sepharose column were desalted on a Sephadex G-50 (fine) column and then loaded on a poly(U)-Sepharose column (50 ,ul) equilibrated in 50 mM Tris/HCl, pH 7.5, 2 mM DTT, 10% glycerol and 0.5 mM PMSF. The column was washed with the same buffer and then with increasing concentrations of KC1 in the same buffer. Enzyme, eluted at 400 mM KCI, was immediately frozen and stored in small aliquots in liquid nitrogen. The final preparation had a specific activity of 1060 units/mg and there was no contamination by nucleases. It had a sedimentation coefficient of 3.5.
Slot-blot analysis
The same number of units (2.5 units) or the same amount of proteins (250 ng) of HSV1 and human uracil-DNA glycosylases were loaded on a nitrocellulose filter in a slot-blot filtration manifold (Hoefer). After a wash with phosphate-buffered saline, the filter was removed and processed as described (Towbin et al., 1979 ). 
Synthesis of Inhibitors
The syntheses of several of the compounds tested have been described (Baker and Rzeszotarski, 1968; . New 6-(p-alkylanilino)uracils were prepared by reaction between 6-chlorouracil and thep-alkylanilines (Aldrich Chemical
Co.) in refluxing 2-methoxyethanol as described . Yields and properties of new compounds are presented in Table 2 . Proton n.m.r. spectra of all compounds in [2H6]dimethyl sulphoxide (300 MHz; Varian Unity 300 instrument) were fully consistent with the proposed structures.
RESULTS
Induction of HSV1 uracil-DNA glycosylase HSV1-infected HeLa cells were collected at 0, 2, 4, 6, 8, 10, 12 and 18 h post-infection, and their cytoplasmic and nuclear fractions were tested for uracil-DNA glycosylase activity. Most of the enzyme activity was present in the nuclear fraction (results not shown) with a peak at 8 h after infection (Figure 1) , indicating a viral induction of the enzyme.
Purfflcation of HSVI uracil-DNA glycosylase
The enzyme was purified from the nuclei of HSVl-infected HeLa cells at the peak of enzyme induction, as described in the Materials and methods section, and Table 1 summarizes the yields and degree of purification obtained. Since most of the inducible uracil-DNA glycosylase activity was observed in the nuclei we used only the nuclear fraction as starting material. The purification sequence resulted in an enzyme preparation with a specific activity of 11080 units/mg and there was no contamination by nucleases. For comparative studies, the human uracil-DNA glycosylase was purified from HeLa cells based on the method of Krokan and Wittwer (1981) (see the Materials and methods section). The latter preparation had a specific activity of 1060 units/mg, with no contamination by nucleases. The lower specific activity of the human compared with the viral enzymic preparation may be due to: (i) the 5-fold higher protein concentration of the human crude extract derived from the cellular cytoplasm, (ii) the low levels of human uracil-DNA glycosylase activity in non-infected cells compared with the high levels of the viral-induced activity at the time of induction, and (iii) the (Arenaz and Sirover, 1983) , kindly supplied by Professor M. Sirover, as described in the Materials and methods section. greater stability of the viral uracil-DNA glycosylase during the purification. The electrophoretic pattern of the viral enzyme was compared with that of the human enzyme by SDS/PAGE (Figure 2 ). Both enzymes showed a band at a molecular mass of 37 kDa, but the human enzyme had higher molecular mass bands as well. This apparent molecular mass of 37 kDa is consistent with the reported molecular masses of 39 kDa for the HSV1 enzyme (Caradonna et al., 1987) and 37 kDa for the human placental enzyme (Seal et al., 1987) . That the uracil-DNA glycosylase isolated from virus-infected HeLa cells is indeed viral in origin was demonstrated by a slotblot experiment with a monoclonal antibody to the human placenta enzyme (Arenaz and Sirover, 1983) . Figure 3 shows that 4-Hydroxy 3,4-Dimethoxy 3,4-Dichloro 3-Ethyl-4-methyl 4-n-Propyl 4-isopropyl 4-n-Butyl (BuAU) 4-Isobutyl 4-n-Pentyl 4-isopentyl 4-n-Hexyl (HexAU) 4-n-Heptyl 4-n-Octyl (OctAU) Figure 4 Dose-response curves tor uracli-ONA glycosylase inhibition by 6-(p-n-alkylanilino)uracils
The HSV1 (0) and human (0) enzymes were assayed as described in the Materials and methods section with the addition of stock solutions of inhibitors dissolved in dimethyl-sulphoxide. Control activity corresponds to enzyme activity in the presence of an identical concentration of the solvent. PentAU, 6-(pn-pentylanilino)uracil; HeptAU, 6-(p-n-heptylanilino)uracil.
DNA glycosylases revealed several 6-anilinouracils that showed weak activity against the viral enzyme. Many substituted derivatives were only marginally active at 500 ,uM in inhibiting the release of [3H]uracil in the standard uracil-DNA glycosylase assay (see the Materials and methods section), but 6-(p-nbutylanilino)uracil (BuAU) inhibited the viral enzyme by 50 % at 150 ,uM and was ineffective at 500 ,uM against the human enzyme. This result prompted the synthesis and testing of additional palkyl derivatives in an attempt to identify more potent and selective inhibitors of the HSV1 enzyme. The properties of these new compounds are summarized in Table 2 . The results of testing of representative 6-anilinouracils and the new derivatives are summarized numerically in Table 3 , and the selectivity of the more potent inhibitors is displayed graphically in Figure 4 . 6-Anilinouracils with n-alkyl groups in thep position of the anilino ring were progressively more potent as inhibitors of the HSV1 enzyme and retained a high degree of selectivity for the viral enzyme. The most potent compound, 6-(p-n-octylanilino)uracil (OctAU) had an IC50 of 8 ,uM against the viral enzyme, but one of > 300 ,uM, the highest concentration tested, against the human enzyme. Interestingly, the n-heptyl derivative was less selective than the n-hexyl or n-octyl derivatives (Figure 4 ). Both the nhexyl and n-octyl derivatives were found to be inactive against viral TK and DNA polymerase (results not shown).
Mechanism of Inhibition
Insight into the mechanism by which 6-(p-alkylanilino)uracils inhibit HSV1 uracil-DNA glycosylase was sought by studying the dependence ofinhibition on the concentration ofthe substrate in the reaction. The effect of OctAU at varying concentrations of uracil, as dUMP concentration in DNA, are displayed in the double-reciprocal plot in Figure 5 . The results suggest that the Figure  6 show that HexAU did not affect DNA synthesis by HeLa cells at 300 ,#M, but OctAU inhibited DNA synthesis even at 5 ,uM.
The apparent IC50 for the effect of OctAU was about 25 ,uM, but even concentrations as high as 300,uM did not completely suppress thymidine incorporation ( Figure 6 ). The effect ofOctAU on cellular DNA synthesis is similar to that previously reported for the analogue BuAU, a selective inhibitor of DNA polymerase a . BuAU inhibited the incorporation of [3H]thymidine by HeLa cells in culture, but not incorporation of labelled uridine or leucine, markers for RNA and protein synthesis respectively. Thus, although OctAU is a more potent inhibitor of HSVl uracil-DNA glycosylase than HexAU, the latter compound lacks an effect on cellular DNA synthesis at concentrations at which the viral enzyme is strongly inhibited. The unexpected observation that OctAU inhibited [3H]-thymidine incorporation by HeLa cells in culture, and the similarity of its structure to that of a selective inhibitor of DNA polymerase a, BuAU , prompted us to ask if this new derivative inhibited one or more of the eukaryotic replicative DNA polymerases a, a and e. In standard DNA polymerase reactions with nicked DNA, assayed as described (Weiser et al., 1991) , OctAU had little effect on HeLa DNA polymerase a (IC50 > 500 uM), but inhibited HeLa DNA polymerase e with an IC50 of 80 ,uM. HexAU, on the other hand, weakly inhibited both enzymes (IC50 > 500 ,M) under these conditions, thus explaining the lack of effect of this compound on cellular DNA synthesis. Furthermore, both DNA polymerases e and a [proliferating cell nuclear antigen (PCNA)-dependent] from calf thymus were more sensitive to OctAU than polymerase a (results not shown). These results suggest that OctAU may represent a prototype of selective inhibitors of DNA polymerase a and/or e, just as BuAU was the prototype of a series of useful selective inhibitors of DNA polymerase a (Brown et al., 1986) .
DISCUSSION
The DNA repair enzyme uracil-DNA glycosylase has been purified from HSVl-infected HeLa cells. By comparison with the enzyme isolated from uninfected HeLa cells, this enzyme has been shown to be of viral origin by virtue of: (1) its timedependent induction upon virus infection of cells ( Figure 1) ; (2) its apparent molecular mass of 37 kDa (Figure 2) , and (3) its insensitivity to a monoclonal antibody to the human enzyme (Figure 3) . The enzyme further differs from its cellular counterpart in its potent and selective inhibition by 6-(p-n-alkylanilino) uracils (Table 3 ), compounds that appear to act mechanistically as substrate analogues. The enzyme isolated from HeLa cells was consistently less sensitive to inhibition by all compounds in this series.
Few inhibitors of uracil-DNA glycosylases have been reported. Among a group of simple pyrimidines, only uracil was found to inhibit the enzyme from leukaemic blast cells (Caradonna and Cheng, 1980) ; uracil caused 81 % inhibition at 1 mM, and was non-competitive with the substrate (as [dUMP] ). Uracil, 6-aminouracil and 5-azauracil were reported to inhibit uracil-DNA glycosylase from HeLa cells, but with IC50 values of 1-2 mM (Krokan and Wittwer, 1981) . In contrast, 5-fluorouracil and 5-bromouracil at 1 mM inhibited uracil-DNA glycosylase from human placenta only after preincubation with the enzyme at 4°C (Seal et al., 1987) . Neither the 2'-deoxyribonucleosides nor the corresponding 5'-monophosphates of the 5-halouracils substantially inhibited the placenta enzyme even after the preincubation period. The results in the present paper reveal the first potent and selective inhibitors of the viral uracil-DNA glycosylase that can be used as probes of the mechanism of enzyme action, and these may prove to be useful in studying the role of this enzyme in virus growth and re-activation.
It is known that uracil can arise in DNA by two mechanisms: (i) the misincorporation ofdUMP residues by DNA polymerases, u and (ii) the spontaneous deamination of cytosine. In particular with regard to the nervous system, where herpes viruses establish latency, it is worthwhile to recall that the only DNA polymerase present in adult neurons, DNA polymerase /3, in contrast to the replicative DNA polymerases a and e (which utilize dUTP 70-80 % less efficiently than dTTP), does not discriminate between dUTP and dTTP . This suggests that dUTP could be introduced into DNA during DNA repair in adult neurons, although most of the uracil in DNA results from deamination of cytosine. These observations suggest that dUMP residues may accumulate in DNA during the life-span of adult neurons .
The continuous spontaneous deamination of cytosine, the fact that both viral DNA polymerase (Focher et al., 1992) and DNA polymerase ,3 incorporate dUTP and dTTP with comparable efficiency, and the lack of cellular uracil-DNA glycosylase in nerve cells suggest a role of the virus-encoded uracil-DNA glycosylase in the re-activation and replication of Herpes simplex virus in nerve cells. This role is supported by our finding that uracil in DNA affects specific DNA-protein interactions Focher et al., 1992) .
In conclusion, we hypothesize that HSV1 uracil-DNA glycosylase, which is non-essential for the proliferation of HSV1 in cell cultures, could play a key role in nerve cells in 'cleansing' of the viral genome before DNA replication as well as in the removal of misincorporated uracil during viral DNA replication. We intend to use the specific inhibitors described in this paper in order to verify the role of viral uracil-DNA glycosylase during virus re-activation and replication in nerve cells in vivo. One derivative, HexAU, by virtue of its lack of effect on cellular DNA synthesis and on viral TK and DNA polymerase at concentrations that completely inhibit the viral enzyme, has been selected for such studies.
